Oncology & Cancer

Three 'targeted' cancer drugs raise risk of fatal side effects

Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that ...

Oncology & Cancer

Cancer survival rates are improving in Australia

Cancer survival rates in Australia are continuing to improve and the rate at which Australians are being diagnosed with cancer has been declining since 2008, according to a new report by the Australian Institute of Health ...

Oncology & Cancer

Depleted metabolic enzymes promote tumor growth in kidney cancer

Kidney cancer, one of the ten most prevalent malignancies in the world, has increased in incidence over the last decade, likely due to rising obesity rates. The most common subtype of this cancer is "clear cell" renal cell ...

Oncology & Cancer

New findings provide more complete picture of kidney cancer

Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments.

page 8 from 34